NBIX - Neurocrine Biosciences Inc logo

NBIX

Neurocrine Biosciences Inc

Neurocrine Biosciences develops and commercializes pharmaceuticals targeting neurological, psychiatric, endocrine, and immunological disorders. Key products include INGREZZA for tardive dyskinesia, Orilissa for endometriosis, and treatments for various movement disorders.

⚕️ Healthcare🏦 NASDAQ📅 Listed 1996💱 $ USD
💰 $1,000 invested 20 years ago$2,899today

Score Overview

1 Year
⭐ Score7.8
📈 Net Growth39.70%
⌛ Net Trend100%
📶 Net Stab.
📈 Rev Growth8.46%
⌛ Rev Trend100%
📶 Rev Stab.
5 Years
⭐ Score9.4
📈 Net Growth6x
⌛ Net Trend100%
📶 Net Stab.
📈 Rev Growth173.70%
⌛ Rev Trend100%
📶 Rev Stab.
10 Years
⭐ Score7.6
📈 Net Growth5x
⌛ Net Trend80%
📶 Net Stab.0%
📈 Rev Growth205x
⌛ Rev Trend100%
📶 Rev Stab.89%
20 Years
⭐ Score6.5
📈 Net Growth7x
⌛ Net Trend60%
📶 Net Stab.0%
📈 Rev Growth78x
⌛ Rev Trend70%
📶 Rev Stab.0%
All Time
⭐ Score4.6
📈 Net Growth112x
⌛ Net Trend50%
📶 Net Stab.0%
📈 Rev Growth160x
⌛ Rev Trend63%
📶 Rev Stab.0%

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-05-11
$ 150.59
1 Year2025-05-09
$ 115.7130.14%
5 Years2021-05-11
$ 91.4564.67%
10 Years2016-05-11
$ 42.65253.08%
20 Years2006-05-11
$ 51.95189.87%
All Time1996-05-23
$ 12.5012x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 3.10B$ 668M$ 1.31B
2025$ 2.86B$ 478M$ 1.48B
2024$ 2.35B$ 341M$ 1.07B
2023$ 1.88B$ 249M$ 1.03B
2022$ 1.48B$ 154M$ 989M
2021$ 1.13B$ 89M$ 711M
2020$ 1.04B$ 407M$ 801M
2019$ 788M$ 37M$ 670M
2018$ 451M$ 21M$ 650M
2017$ 161M-$ 142M$ 515M
2016$ 15M-$ 141M$ 307M
2015$ 19M-$ 88M$ 379M
2014$ 0.00-$ 60M$ 193M
2013$ 2M-$ 46M$ 145M
2012$ 53M$ 5M$ 173M
2011$ 77M$ 37M$ 129M
2010$ 33M-$ 7M$ 126M
2009$ 2M-$ 51M$ 53M
2008$ 3M-$ 88M$ 80M
2007$ 1M-$ 207M$ 179M
2006$ 39M-$ 107M$ 182M
2005$ 123M-$ 22M$ 273M
2004$ 85M-$ 45M$ 301M
2003$ 139M-$ 30M$ 453M
2002$ 18M-$ 94M$ 244M
2001$ 41M-$ 36M$ 319M
2000$ 14M-$ 28M$ 164M
1999$ 16M-$ 16M$ 91M
1998$ 16M-$ 20M$ 11M
1997$ 26M$ 5M$ 15M
IPO1996$ 19M$ 5M$ 11M